Skip to main content
Eric Duncavage, MD, Pathology, Saint Louis, MO

EricJamesDuncavageMD

Pathology Saint Louis, MO

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Immunology, Washington University School of Medicine

Dr. Duncavage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Duncavage's full profile

Already have an account?

  • Office

    1 Barnes Jewish Hospital Plz
    # Div
    Saint Louis, MO 63110
    Phone+1 314-362-5641
    Fax+1 314-362-0369

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Hematopathology, 2009 - 2010
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Molecular Genetic Pathology, 2008 - 2009
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2004 - 2008
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2014 - 2026
  • MO State Medical License
    MO State Medical License 2007 - 2025
  • UT State Medical License
    UT State Medical License 2009 - 2012
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Clinical Informatics
  • American Board of Pathology Pathology - Molecular Genetic
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • TP53 Immunohistochemistry Correlates TP53 Mutation Status and Clearance in Decitabine-Treated Patients with Myeloid Malignancies  
    John S Welch, Eric J Duncavage, Haematologica
  • Exome Analysis of Treatment‐Related AML After APL Suggests Secondary Evolution  
    John S Welch, Eric J Duncavage, Meagan A Jacoby, Peter Westervelt, Lukas D Wartman, British Journal of Haematology
  • Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS  
    Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature

Abstracts/Posters

  • TGF-_ Signaling Contributes to Myelofibrosis and Clonal Dominance of Myeloproliferative Neoplasms
    Eric J. Duncavage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
    Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to ImmunotherapyNovember 7th, 2024
  • As Use of Large Cancer Panels and Whole-Genome Sequencing Expands, Illumina Plans to Future-Proof NGS Interpretation and Reporting
    As Use of Large Cancer Panels and Whole-Genome Sequencing Expands, Illumina Plans to Future-Proof NGS Interpretation and ReportingMarch 28th, 2023
  • More Precise Treatment Decisions Rely on Better Biomarkers
    More Precise Treatment Decisions Rely on Better BiomarkersJune 6th, 2019
  • Join now to see all